Author

John M. Feigert

Observed names: J M Feigert, J. Feigert, John Feigert

Institution: Virginia Cancer Specialists

Observed institutions: Roswell Park Comprehensive Cancer Center, Thomas Jefferson University, Georgetown University, Moffitt Cancer Center, Dana-Farber Cancer Institute, Novartis (United States), Virginia Cancer Specialists, Columbia University

OpenAlex ID: A5013235199

Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome

2012 · Alan F. List, Maria R. Baer, et al. · Journal of Clinical Oncology · 172

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

2015 · Uwe Platzbecker, Raymond S M Wong, et al. · The Lancet Haematology · 81

A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression

1998 · Roy A. Beveridge, John A. Miller, et al. · Cancer Investigation · 66

Multicentric Angiofollicular Lymph Node Hyperplasia with Peripheral Neuropathy, Pseudotumor Cerebri, IgA Dysproteinemia, and Thrombocytosis in Women

1990 · John M. Feigert, Donald L. Sweet, et al. · Annals of Internal Medicine · 47

Iron Chelation with Deferasirox (Exjade®) Improves Iron Burden in Patients with Myelodysplastic Syndromes (MDS)

2008 · Alan F List, Maria R Baer, et al. · Blood · 31

Deferasirox (ICL670; Exjade®) Reduces Serum Ferritin (SF) and Labile Plasma Iron (LPI) in Patients with Myelodysplastic Syndromes (MDS).

2007 · Alan F. List, M.R. Baer, et al. · Blood · 24

Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.

2009 · Alan F. List, Maria R. Baer, et al. · Blood · 16

Oncologists' Experience in Reporting Cancer Staging and Guideline Adherence: Lessons From the 2006 Medicare Oncology Demonstration

2010 · Julia Doherty, Myra Tanamor, et al. · Journal of Oncology Practice · 7

High-grade B-cell lymphoma masquerading as peritoneal lymphomatosis

2019 · Samuel Kareff, Chao Yin, et al. · BMJ Case Reports · 5

Randomized, Placebo-Controlled, Phase I/II Trial Of The Thrombopoietin Receptor Agonist Eltrombopag In Thrombocytopenic Patients With Advanced Myelodysplastic Syndromes Or Acute Myeloid Leukemia — A Subgroup Analysis Of Patients Receiving Concomitant Anticancer Therapy

2013 · Uwe Platzbecker, Raymond S.M. Wong, et al. · Blood · 4

Rapidly progressive prostate cancer in the primary care setting.

1997 · S H Woolf, R Mugol, et al. · PubMed

Works count: 11

Citation count: 453

H-index: 7

I10-index: 7